Liver Care Tablet Franchise in Ahmedabad

Hepatology Medicine Supplier in Mumbai

Liver Medicine Distributor in Delhi

UDCA Tablet Manufacturer in Bangalore

Liver Tablet Stockist in Hyderabad
Liver Medicine Exporter in Chandigarh

Home/Products /s-adenosyl-l-methionine-400-mg-ursodeoxycholic-acid-300-mg-tablet

Hepalogy U Tablet

Composition : S-Adenosyl-L Methionine (400 mg) + Ursodeoxycholic Acid (300 mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Hepalogy U Tablet containing S-Adenosyl-L-Methionine and Ursodeoxycholic Acid is used for the management of liver disorders. It helps in improving liver function, enhancing bile flow, and supporting overall hepatic health.

S-Adenosyl-L-Methionine supports liver cell regeneration and detoxification, while Ursodeoxycholic Acid improves bile secretion and reduces liver stress. This combination helps in maintaining healthy liver function and reducing symptoms associated with liver conditions.

The tablet is widely prescribed in hepatology practice for various liver disorders, leading to consistent demand and long-term usage in clinical settings.

With increasing prevalence of liver diseases and rising awareness of liver health, this product offers strong business potential for retailers and distributors. Its regular prescription demand, long-term therapy usage, and growing acceptance make it a reliable product for consistent sales and growth in the hepatology segment.

Read More

About the Product

Hepalogy U Tablet containing S-Adenosyl-L-Methionine and Ursodeoxycholic Acid is used for the management of liver disorders. It helps in improving liver function, enhancing bile flow, and supporting overall hepatic health.

S-Adenosyl-L-Methionine supports liver cell regeneration and detoxification, while Ursodeoxycholic Acid improves bile secretion and reduces liver stress. This combination helps in maintaining healthy liver function and reducing symptoms associated with liver conditions.

The tablet is widely prescribed in hepatology practice for various liver disorders, leading to consistent demand and long-term usage in clinical settings.

With increasing prevalence of liver diseases and rising awareness of liver health, this product offers strong business potential for retailers and distributors. Its regular prescription demand, long-term therapy usage, and growing acceptance make it a reliable product for consistent sales and growth in the hepatology segment.

Some patients may experience mild gastrointestinal discomfort, diarrhea, nausea, or abdominal pain. Rarely, allergic reactions or changes in liver parameters may occur and require medical attention.

Hepalogy U Tablet is indicated for the management of liver disorders such as cholestatic liver disease, fatty liver, drug-induced liver injury, and other hepatic dysfunctions. It helps improve liver enzyme levels, reduce bile stasis, support liver regeneration, and enhance digestive function.

This medicine should be used under medical supervision. Regular monitoring of liver function tests is recommended during therapy. Patients with severe liver disease or those taking other medications should consult their healthcare provider before use.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation